Annual Retained Earnings
-$172.16 M
-$5.69 M-3.42%
December 31, 2023
Summary
- As of February 7, 2025, FRTX annual retained earnings is -$172.16 million, with the most recent change of -$5.69 million (-3.42%) on December 31, 2023.
- During the last 3 years, FRTX annual retained earnings has fallen by -$66.27 million (-62.58%).
- FRTX annual retained earnings is now -2974.34% below its all-time high of -$5.60 million, reached on December 1, 1990.
Performance
FRTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$172.16 M
-$1.24 M-0.72%
December 31, 2023
Summary
- As of February 7, 2025, FRTX quarterly retained earnings is -$172.16 million, with the most recent change of -$1.24 million (-0.72%) on December 31, 2023.
- Over the past year, FRTX quarterly retained earnings has dropped by -$1.24 million (-0.72%).
- FRTX quarterly retained earnings is now -2974.34% below its all-time high of -$5.60 million, reached on December 1, 1990.
Performance
FRTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
FRTX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.4% | -0.7% |
| 3 y3 years | -62.6% | -0.7% |
| 5 y5 years | +61.0% | -0.7% |
FRTX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.4% | at low | -18.4% | +0.5% |
| 5 y | 5-year | -102.6% | at low | -102.6% | +0.5% |
| alltime | all time | -2974.3% | +61.0% | -2974.3% | +61.7% |
Fresh Tracks Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -$172.16 M(+3.4%) | -$172.16 M(+0.7%) |
| Sep 2023 | - | -$170.93 M(-1.2%) |
| Jun 2023 | - | -$173.03 M(+1.3%) |
| Mar 2023 | - | -$170.75 M(+2.6%) |
| Dec 2022 | -$166.47 M(+14.5%) | -$166.47 M(+2.8%) |
| Sep 2022 | - | -$161.94 M(+3.9%) |
| Jun 2022 | - | -$155.92 M(+0.7%) |
| Mar 2022 | - | -$154.78 M(+6.5%) |
| Dec 2021 | -$145.37 M(+37.3%) | - |
| Dec 2021 | - | -$145.37 M(+4.4%) |
| Sep 2021 | - | -$139.30 M(+10.5%) |
| Jun 2021 | - | -$126.05 M(+9.7%) |
| Mar 2021 | - | -$114.90 M(+8.5%) |
| Dec 2020 | -$105.89 M(+24.6%) | -$105.89 M(+7.5%) |
| Sep 2020 | - | -$98.53 M(+4.6%) |
| Jun 2020 | - | -$94.20 M(+5.7%) |
| Mar 2020 | - | -$89.08 M(+4.8%) |
| Dec 2019 | -$84.98 M(-80.8%) | -$84.98 M(+14.7%) |
| Sep 2019 | - | -$74.12 M(-83.5%) |
| Jun 2019 | - | -$449.07 M(+0.5%) |
| Mar 2019 | - | -$446.64 M(+1.0%) |
| Dec 2018 | -$442.06 M(+3.6%) | -$442.06 M(+0.8%) |
| Sep 2018 | - | -$438.46 M(+0.3%) |
| Jun 2018 | - | -$436.95 M(+1.1%) |
| Mar 2018 | - | -$432.08 M(+1.3%) |
| Dec 2017 | -$426.74 M(+3.1%) | -$426.74 M(+0.9%) |
| Sep 2017 | - | -$423.01 M(+0.7%) |
| Jun 2017 | - | -$419.92 M(+0.8%) |
| Mar 2017 | - | -$416.60 M(+0.7%) |
| Dec 2016 | -$413.88 M(+2.2%) | -$413.88 M(+0.7%) |
| Sep 2016 | - | -$411.11 M(+0.6%) |
| Jun 2016 | - | -$408.58 M(+0.3%) |
| Mar 2016 | - | -$407.33 M(+0.6%) |
| Dec 2015 | -$404.90 M(+2.3%) | -$404.90 M(+0.6%) |
| Sep 2015 | - | -$402.55 M(+0.1%) |
| Jun 2015 | - | -$402.25 M(+0.7%) |
| Mar 2015 | - | -$399.49 M(+1.0%) |
| Dec 2014 | -$395.67 M(+4.3%) | -$395.67 M(+1.2%) |
| Sep 2014 | - | -$391.03 M(+1.1%) |
| Jun 2014 | - | -$386.67 M(+1.1%) |
| Mar 2014 | - | -$382.63 M(+0.9%) |
| Dec 2013 | -$379.18 M(+9.0%) | -$379.18 M(+0.6%) |
| Sep 2013 | - | -$376.98 M(+2.7%) |
| Jun 2013 | - | -$367.10 M(+2.8%) |
| Mar 2013 | - | -$357.22 M(+2.7%) |
| Dec 2012 | -$347.94 M(+7.0%) | -$347.94 M(+2.2%) |
| Sep 2012 | - | -$340.39 M(+2.3%) |
| Jun 2012 | - | -$332.66 M(+2.4%) |
| Mar 2012 | - | -$324.79 M(-0.1%) |
| Dec 2011 | -$325.04 M(+2.3%) | -$325.04 M(+2.1%) |
| Sep 2011 | - | -$318.42 M(-4.9%) |
| Jun 2011 | - | -$334.86 M(+2.6%) |
| Mar 2011 | - | -$326.45 M(+2.7%) |
| Dec 2010 | -$317.75 M(+10.6%) | -$317.75 M(+2.2%) |
| Sep 2010 | - | -$311.00 M(+2.2%) |
| Jun 2010 | - | -$304.23 M(+2.8%) |
| Mar 2010 | - | -$295.85 M(+3.0%) |
| Dec 2009 | -$287.37 M(+11.0%) | -$287.37 M(+2.6%) |
| Sep 2009 | - | -$280.06 M(+2.6%) |
| Jun 2009 | - | -$273.08 M(+2.3%) |
| Mar 2009 | - | -$267.06 M(+3.2%) |
| Dec 2008 | -$258.81 M | -$258.81 M(+3.6%) |
| Sep 2008 | - | -$249.79 M(+4.1%) |
| Jun 2008 | - | -$239.96 M(+3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | -$231.48 M(+4.3%) |
| Dec 2007 | -$221.92 M(+19.3%) | -$221.92 M(+4.2%) |
| Sep 2007 | - | -$213.06 M(+4.5%) |
| Jun 2007 | - | -$203.82 M(+4.2%) |
| Mar 2007 | - | -$195.62 M(+5.2%) |
| Dec 2006 | -$186.02 M(+14.2%) | -$186.02 M(+4.4%) |
| Sep 2006 | - | -$178.10 M(+4.4%) |
| Jun 2006 | - | -$170.59 M(+1.9%) |
| Mar 2006 | - | -$167.35 M(+2.7%) |
| Dec 2005 | -$162.87 M(+17.6%) | -$162.87 M(+3.6%) |
| Sep 2005 | - | -$157.21 M(+4.1%) |
| Jun 2005 | - | -$151.08 M(+3.4%) |
| Mar 2005 | - | -$146.09 M(+5.5%) |
| Dec 2004 | -$138.52 M(+20.7%) | -$138.52 M(+3.3%) |
| Sep 2004 | - | -$134.05 M(+3.8%) |
| Jun 2004 | - | -$129.18 M(+4.3%) |
| Mar 2004 | - | -$123.86 M(+7.9%) |
| Dec 2003 | -$114.78 M(+27.1%) | -$114.78 M(+6.4%) |
| Sep 2003 | - | -$107.84 M(+3.4%) |
| Jun 2003 | - | -$104.28 M(+7.1%) |
| Mar 2003 | - | -$97.36 M(+7.8%) |
| Dec 2002 | -$90.33 M(+44.8%) | -$90.33 M(+9.0%) |
| Sep 2002 | - | -$82.86 M(+94.3%) |
| Jun 2002 | - | -$42.65 M(-36.9%) |
| Mar 2002 | - | -$67.63 M(+8.4%) |
| Dec 2001 | -$62.40 M(+17.4%) | -$62.40 M(+2.3%) |
| Sep 2001 | - | -$60.97 M(+4.4%) |
| Jun 2001 | - | -$58.42 M(+5.9%) |
| Mar 2001 | - | -$55.14 M(+3.7%) |
| Dec 2000 | -$53.16 M(+19.2%) | -$53.16 M(+5.8%) |
| Sep 2000 | - | -$50.25 M(+3.9%) |
| Jun 2000 | - | -$48.37 M(+1.7%) |
| Mar 2000 | - | -$47.56 M(+6.6%) |
| Dec 1999 | -$44.60 M(+18.3%) | -$44.60 M(+0.2%) |
| Sep 1999 | - | -$44.50 M(+7.0%) |
| Jun 1999 | - | -$41.60 M(+8.1%) |
| Mar 1999 | - | -$38.50 M(+2.1%) |
| Dec 1998 | -$37.70 M(+24.4%) | -$37.70 M(+5.6%) |
| Sep 1998 | - | -$35.70 M(+5.3%) |
| Jun 1998 | - | -$33.90 M(+9.4%) |
| Mar 1998 | - | -$31.00 M(+2.3%) |
| Dec 1997 | -$30.30 M(+23.2%) | -$30.30 M(+4.1%) |
| Sep 1997 | - | -$29.10 M(+0.7%) |
| Jun 1997 | - | -$28.90 M(+8.6%) |
| Mar 1997 | - | -$26.60 M(+8.1%) |
| Dec 1996 | -$24.60 M(+25.5%) | -$24.60 M(+5.6%) |
| Sep 1996 | - | -$23.30 M(+10.4%) |
| Jun 1996 | - | -$21.10 M(-1.9%) |
| Mar 1996 | - | -$21.50 M(+9.7%) |
| Dec 1995 | -$19.60 M(+25.6%) | -$19.60 M(+7.7%) |
| Sep 1995 | - | -$18.20 M(+6.4%) |
| Jun 1995 | - | -$17.10 M(0.0%) |
| Mar 1995 | - | -$17.10 M(+9.6%) |
| Dec 1994 | -$15.60 M(+39.3%) | -$15.60 M(+14.7%) |
| Sep 1994 | - | -$13.60 M(+5.4%) |
| Jun 1994 | - | -$12.90 M(+3.2%) |
| Mar 1994 | - | -$12.50 M(+11.6%) |
| Dec 1993 | -$11.20 M(+13.1%) | -$11.20 M(+9.8%) |
| Sep 1993 | - | -$10.20 M(+12.1%) |
| Jun 1993 | - | -$9.10 M(+13.8%) |
| Mar 1993 | - | -$8.00 M(-19.2%) |
| Dec 1992 | -$9.90 M(+25.3%) | -$9.90 M(+25.3%) |
| Dec 1991 | -$7.90 M(+41.1%) | -$7.90 M(+41.1%) |
| Dec 1990 | -$5.60 M | -$5.60 M |
FAQ
- What is Fresh Tracks Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics annual retained earnings year-on-year change?
- What is Fresh Tracks Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics quarterly retained earnings year-on-year change?
What is Fresh Tracks Therapeutics annual retained earnings?
The current annual retained earnings of FRTX is -$172.16 M
What is the all time high annual retained earnings for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high annual retained earnings is -$5.60 M
What is Fresh Tracks Therapeutics annual retained earnings year-on-year change?
Over the past year, FRTX annual retained earnings has changed by -$5.69 M (-3.42%)
What is Fresh Tracks Therapeutics quarterly retained earnings?
The current quarterly retained earnings of FRTX is -$172.16 M
What is the all time high quarterly retained earnings for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high quarterly retained earnings is -$5.60 M
What is Fresh Tracks Therapeutics quarterly retained earnings year-on-year change?
Over the past year, FRTX quarterly retained earnings has changed by -$1.24 M (-0.72%)